Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0MR4N
|
||||
| Former ID |
DNC012339
|
||||
| Drug Name |
1-(4-Butyl-thiazol-2-yl)-3-phenethyl-thiourea
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H21N3S2
|
||||
| Canonical SMILES |
CCCCC1=CSC(=N1)NC(=S)NCCC2=CC=CC=C2
|
||||
| InChI |
1S/C16H21N3S2/c1-2-3-9-14-12-21-16(18-14)19-15(20)17-11-10-13-7-5-4-6-8-13/h4-8,12H,2-3,9-11H2,1H3,(H2,17,18,19,20)
|
||||
| InChIKey |
SXKJLZJKVYKNHV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV-1 reverse transcriptase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.